MedTrace Logo

Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections

NCT02060513 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2298

Last updated 2025-12-12

No results posted yet for this study

Summary

Military service members and the U.S. veteran population face a growing and serious health threat: widespread antibiotic resistance resulting from resistant bacteria and a dwindling pipe-line of sufficiently potent antibiotics. Infections with antibiotic resistant bacteria are increasing significantly. They cause major complications and mortality, and drive up healthcare costs. Powerful but non-targeted antibiotics, while in widespread use, can actually pressure bacteria to develop resistance.

Conditions

  • Infection
  • Skin and Subcutaneous Tissue Bacterial Infections
  • Healthcare-associated Infection
  • Infection Due to Resistant Bacteria

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Accelerate Diagnostics, Inc.

    collaborator INDUSTRY

  • Connie Price

    lead OTHER

Principal Investigators

  • Connie S Price, MD · Denver Health Medical Center

  • Ivor S Douglas, MD · Denver Health Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02060513 on ClinicalTrials.gov